| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 19 | 2021 | 586 | 2.630 |
Why?
|
| Information Storage and Retrieval | 11 | 2011 | 127 | 1.950 |
Why?
|
| Models, Genetic | 17 | 2013 | 984 | 1.570 |
Why?
|
| Natural Language Processing | 10 | 2009 | 42 | 1.360 |
Why?
|
| Research | 4 | 2015 | 265 | 1.350 |
Why?
|
| Periodicals as Topic | 11 | 2008 | 171 | 1.310 |
Why?
|
| Artificial Intelligence | 12 | 2010 | 398 | 1.170 |
Why?
|
| Disease | 4 | 2017 | 93 | 1.130 |
Why?
|
| Seasons | 5 | 2021 | 246 | 1.060 |
Why?
|
| Vocabulary, Controlled | 8 | 2014 | 12 | 0.910 |
Why?
|
| Models, Statistical | 8 | 2021 | 594 | 0.880 |
Why?
|
| Models, Biological | 11 | 2011 | 1809 | 0.840 |
Why?
|
| Biomedical Research | 4 | 2019 | 441 | 0.810 |
Why?
|
| Science | 2 | 2015 | 37 | 0.780 |
Why?
|
| Orthomyxoviridae | 2 | 2018 | 48 | 0.760 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 5 | 2021 | 85 | 0.720 |
Why?
|
| Genetic Loci | 1 | 2023 | 260 | 0.720 |
Why?
|
| Sex Ratio | 1 | 2021 | 23 | 0.710 |
Why?
|
| Software | 12 | 2014 | 698 | 0.710 |
Why?
|
| Proteins | 10 | 2007 | 816 | 0.690 |
Why?
|
| Population Dynamics | 1 | 2021 | 144 | 0.680 |
Why?
|
| Genes | 7 | 2007 | 307 | 0.670 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 188 | 0.670 |
Why?
|
| Models, Theoretical | 9 | 2018 | 503 | 0.660 |
Why?
|
| Signal Transduction | 11 | 2021 | 3581 | 0.660 |
Why?
|
| Protein Interaction Mapping | 4 | 2005 | 81 | 0.650 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 125 | 0.650 |
Why?
|
| Sociology | 2 | 2010 | 2 | 0.630 |
Why?
|
| Global Health | 1 | 2021 | 213 | 0.630 |
Why?
|
| Staphylococcal Infections | 5 | 2021 | 289 | 0.630 |
Why?
|
| Mental Disorders | 2 | 2021 | 463 | 0.620 |
Why?
|
| Drug Discovery | 3 | 2022 | 118 | 0.620 |
Why?
|
| Electronic Health Records | 4 | 2021 | 372 | 0.600 |
Why?
|
| Phylogeny | 16 | 2004 | 1275 | 0.590 |
Why?
|
| Data Mining | 3 | 2014 | 44 | 0.590 |
Why?
|
| Programming Languages | 4 | 2011 | 16 | 0.580 |
Why?
|
| Databases, Factual | 6 | 2009 | 1010 | 0.560 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2019 | 2474 | 0.560 |
Why?
|
| Environment | 2 | 2017 | 231 | 0.550 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 451 | 0.540 |
Why?
|
| Genome-Wide Association Study | 3 | 2023 | 1766 | 0.540 |
Why?
|
| Insurance Claim Reporting | 1 | 2017 | 3 | 0.540 |
Why?
|
| Humans | 71 | 2025 | 95799 | 0.540 |
Why?
|
| Disease Transmission, Infectious | 1 | 2018 | 60 | 0.520 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 151 | 0.520 |
Why?
|
| Genetic Diseases, Inborn | 5 | 2015 | 100 | 0.520 |
Why?
|
| Autistic Disorder | 3 | 2014 | 150 | 0.510 |
Why?
|
| Terminology as Topic | 5 | 2009 | 227 | 0.510 |
Why?
|
| Genetic Variation | 10 | 2018 | 1422 | 0.500 |
Why?
|
| Soft Tissue Infections | 3 | 2021 | 27 | 0.490 |
Why?
|
| United States | 11 | 2023 | 7764 | 0.490 |
Why?
|
| Family Characteristics | 4 | 2020 | 52 | 0.480 |
Why?
|
| Organoids | 3 | 2022 | 78 | 0.470 |
Why?
|
| Phenotype | 8 | 2023 | 2575 | 0.460 |
Why?
|
| Resource Allocation | 1 | 2015 | 67 | 0.450 |
Why?
|
| Genetic Linkage | 2 | 2008 | 620 | 0.440 |
Why?
|
| Research Support as Topic | 1 | 2015 | 92 | 0.440 |
Why?
|
| Health Care Rationing | 1 | 2015 | 85 | 0.440 |
Why?
|
| Influenza, Human | 1 | 2018 | 370 | 0.430 |
Why?
|
| Cost of Illness | 1 | 2015 | 161 | 0.430 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2015 | 137 | 0.430 |
Why?
|
| Computer Simulation | 13 | 2011 | 1158 | 0.420 |
Why?
|
| Asthma | 2 | 2022 | 1051 | 0.420 |
Why?
|
| Biological Evolution | 9 | 2002 | 1030 | 0.400 |
Why?
|
| Sweden | 3 | 2021 | 46 | 0.400 |
Why?
|
| Databases, Bibliographic | 4 | 2009 | 17 | 0.390 |
Why?
|
| Intellectual Disability | 1 | 2014 | 203 | 0.380 |
Why?
|
| Chromosome Mapping | 7 | 2008 | 1080 | 0.370 |
Why?
|
| Cluster Analysis | 3 | 2021 | 393 | 0.360 |
Why?
|
| Mathematical Concepts | 1 | 2011 | 19 | 0.350 |
Why?
|
| Algorithms | 12 | 2019 | 2015 | 0.350 |
Why?
|
| DNA | 5 | 2001 | 1327 | 0.350 |
Why?
|
| Bayes Theorem | 4 | 2021 | 404 | 0.340 |
Why?
|
| Evolution, Molecular | 7 | 2001 | 891 | 0.340 |
Why?
|
| Staphylococcal Skin Infections | 2 | 2021 | 25 | 0.330 |
Why?
|
| Biology | 2 | 2022 | 52 | 0.320 |
Why?
|
| Semantics | 2 | 2008 | 55 | 0.320 |
Why?
|
| Language | 1 | 2011 | 162 | 0.320 |
Why?
|
| Information Dissemination | 2 | 2010 | 126 | 0.310 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2009 | 19 | 0.310 |
Why?
|
| Metabolome | 1 | 2009 | 63 | 0.300 |
Why?
|
| Database Management Systems | 5 | 2009 | 44 | 0.300 |
Why?
|
| User-Computer Interface | 3 | 2011 | 196 | 0.290 |
Why?
|
| Genome, Human | 4 | 2008 | 824 | 0.280 |
Why?
|
| Gene Regulatory Networks | 3 | 2009 | 322 | 0.280 |
Why?
|
| Literature, Modern | 1 | 2008 | 1 | 0.280 |
Why?
|
| Genetic Techniques | 2 | 2001 | 74 | 0.280 |
Why?
|
| Cerebellum | 1 | 2009 | 253 | 0.270 |
Why?
|
| Sensation | 1 | 2008 | 52 | 0.270 |
Why?
|
| Retraction of Publication as Topic | 1 | 2007 | 2 | 0.260 |
Why?
|
| Rural Population | 2 | 2018 | 171 | 0.260 |
Why?
|
| Molecular Biology | 3 | 2005 | 90 | 0.260 |
Why?
|
| RNA, Ribosomal | 3 | 1996 | 72 | 0.260 |
Why?
|
| Publishing | 2 | 2019 | 94 | 0.260 |
Why?
|
| Editorial Policies | 1 | 2007 | 33 | 0.250 |
Why?
|
| Infant, Newborn | 3 | 2021 | 2610 | 0.250 |
Why?
|
| Nerve Tissue Proteins | 1 | 2009 | 515 | 0.250 |
Why?
|
| Databases, Protein | 2 | 2004 | 52 | 0.250 |
Why?
|
| Informatics | 1 | 2006 | 5 | 0.240 |
Why?
|
| Logic | 1 | 2006 | 11 | 0.240 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 198 | 0.240 |
Why?
|
| Multifactorial Inheritance | 1 | 2008 | 202 | 0.240 |
Why?
|
| Markov Chains | 5 | 2014 | 137 | 0.240 |
Why?
|
| Animals | 31 | 2021 | 28889 | 0.230 |
Why?
|
| Gene Expression Regulation | 6 | 2019 | 2061 | 0.230 |
Why?
|
| Multigene Family | 8 | 2008 | 213 | 0.230 |
Why?
|
| Female | 16 | 2022 | 49869 | 0.230 |
Why?
|
| Monte Carlo Method | 4 | 2014 | 191 | 0.230 |
Why?
|
| Patient-Specific Modeling | 1 | 2025 | 24 | 0.220 |
Why?
|
| Male | 13 | 2021 | 45685 | 0.220 |
Why?
|
| Computer Graphics | 2 | 2004 | 102 | 0.210 |
Why?
|
| Child, Preschool | 6 | 2021 | 3970 | 0.210 |
Why?
|
| Proteome | 1 | 2005 | 156 | 0.210 |
Why?
|
| Metabolism | 1 | 2004 | 27 | 0.210 |
Why?
|
| Cell Physiological Phenomena | 1 | 2004 | 27 | 0.210 |
Why?
|
| Risk Factors | 7 | 2020 | 5961 | 0.200 |
Why?
|
| Infant | 5 | 2021 | 3360 | 0.200 |
Why?
|
| Incidence | 3 | 2018 | 1714 | 0.200 |
Why?
|
| Gene Expression Profiling | 3 | 2009 | 1535 | 0.200 |
Why?
|
| Microfluidics | 2 | 2020 | 57 | 0.190 |
Why?
|
| Air Pollution | 2 | 2021 | 107 | 0.190 |
Why?
|
| Community-Acquired Infections | 2 | 2020 | 65 | 0.190 |
Why?
|
| Exons | 4 | 2001 | 454 | 0.190 |
Why?
|
| Pets | 2 | 2020 | 10 | 0.190 |
Why?
|
| Adolescent | 6 | 2021 | 9873 | 0.190 |
Why?
|
| Water Pollution | 1 | 2021 | 10 | 0.180 |
Why?
|
| Carrier State | 2 | 2018 | 40 | 0.180 |
Why?
|
| Child | 7 | 2021 | 7618 | 0.180 |
Why?
|
| Drug Repositioning | 1 | 2021 | 26 | 0.180 |
Why?
|
| Young Adult | 5 | 2021 | 7026 | 0.180 |
Why?
|
| Fluoxetine | 1 | 2021 | 42 | 0.170 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 156 | 0.170 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2002 | 463 | 0.170 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 80 | 0.170 |
Why?
|
| Gene-Environment Interaction | 1 | 2022 | 120 | 0.170 |
Why?
|
| ATP-Binding Cassette Transporters | 4 | 2003 | 142 | 0.170 |
Why?
|
| Datasets as Topic | 1 | 2021 | 82 | 0.170 |
Why?
|
| Geography | 2 | 2018 | 240 | 0.170 |
Why?
|
| Knowledge | 2 | 2011 | 29 | 0.170 |
Why?
|
| Inheritance Patterns | 2 | 2019 | 52 | 0.170 |
Why?
|
| Nervous System Diseases | 2 | 2016 | 172 | 0.170 |
Why?
|
| Aldehyde Dehydrogenase | 2 | 1998 | 17 | 0.170 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2020 | 84 | 0.160 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2020 | 9 | 0.160 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1176 | 0.160 |
Why?
|
| Precision Medicine | 1 | 2025 | 454 | 0.160 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 2882 | 0.160 |
Why?
|
| Regression Analysis | 1 | 2021 | 599 | 0.160 |
Why?
|
| Public Health | 1 | 2021 | 155 | 0.160 |
Why?
|
| Time | 1 | 2020 | 79 | 0.160 |
Why?
|
| Introns | 2 | 2001 | 304 | 0.160 |
Why?
|
| Sea Cucumbers | 1 | 2000 | 1 | 0.160 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 2385 | 0.160 |
Why?
|
| Prevalence | 3 | 2019 | 1349 | 0.160 |
Why?
|
| Sequence Analysis | 2 | 1996 | 28 | 0.160 |
Why?
|
| Amino Acid Substitution | 1 | 2001 | 336 | 0.160 |
Why?
|
| Circadian Rhythm | 2 | 2020 | 299 | 0.160 |
Why?
|
| Automation | 4 | 2022 | 115 | 0.150 |
Why?
|
| Environmental Pollution | 1 | 2019 | 13 | 0.150 |
Why?
|
| Embryo, Nonmammalian | 2 | 2019 | 203 | 0.150 |
Why?
|
| Energy Metabolism | 1 | 2021 | 312 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2004 | 606 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2000 | 130 | 0.150 |
Why?
|
| Receptors, Kainic Acid | 1 | 2019 | 13 | 0.150 |
Why?
|
| Immunoglobulins | 1 | 2000 | 144 | 0.150 |
Why?
|
| Stochastic Processes | 3 | 2004 | 79 | 0.150 |
Why?
|
| Glioblastoma | 1 | 2021 | 285 | 0.150 |
Why?
|
| Cellular Microenvironment | 1 | 2019 | 30 | 0.150 |
Why?
|
| Cystic Fibrosis | 1 | 2020 | 121 | 0.150 |
Why?
|
| Robotics | 1 | 2022 | 273 | 0.150 |
Why?
|
| Social Participation | 1 | 2018 | 16 | 0.140 |
Why?
|
| Disease Reservoirs | 1 | 2018 | 23 | 0.140 |
Why?
|
| Staphylococcus aureus | 2 | 2021 | 285 | 0.140 |
Why?
|
| Hygiene | 1 | 2018 | 10 | 0.140 |
Why?
|
| Eye Diseases | 1 | 2019 | 59 | 0.140 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 69 | 0.140 |
Why?
|
| Epidemiologic Factors | 1 | 2018 | 5 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 2 | 2001 | 910 | 0.140 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 72 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2019 | 284 | 0.140 |
Why?
|
| Supervised Machine Learning | 1 | 2018 | 14 | 0.140 |
Why?
|
| Likelihood Functions | 3 | 2007 | 257 | 0.140 |
Why?
|
| Weather | 1 | 2018 | 6 | 0.140 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2018 | 26 | 0.140 |
Why?
|
| Computer Communication Networks | 1 | 1998 | 24 | 0.140 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2010 | 102 | 0.140 |
Why?
|
| Vascular Diseases | 1 | 2019 | 122 | 0.140 |
Why?
|
| Urethritis | 1 | 2017 | 2 | 0.130 |
Why?
|
| Adult | 8 | 2021 | 28578 | 0.130 |
Why?
|
| Cystitis | 1 | 2017 | 13 | 0.130 |
Why?
|
| Genomics | 2 | 2015 | 857 | 0.130 |
Why?
|
| Behavior | 1 | 2018 | 87 | 0.130 |
Why?
|
| Aged | 6 | 2021 | 20848 | 0.130 |
Why?
|
| Travel | 1 | 2018 | 73 | 0.130 |
Why?
|
| Base Sequence | 5 | 2001 | 2342 | 0.130 |
Why?
|
| Activities of Daily Living | 1 | 2018 | 216 | 0.130 |
Why?
|
| Urban Population | 1 | 2018 | 240 | 0.130 |
Why?
|
| Migraine Disorders | 1 | 2017 | 42 | 0.130 |
Why?
|
| Drosophila | 3 | 2001 | 539 | 0.130 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2017 | 46 | 0.130 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 206 | 0.130 |
Why?
|
| Th2 Cells | 1 | 2017 | 151 | 0.130 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2019 | 325 | 0.130 |
Why?
|
| RNA | 2 | 2001 | 604 | 0.130 |
Why?
|
| Social Media | 1 | 2018 | 112 | 0.120 |
Why?
|
| Skin | 1 | 2019 | 604 | 0.120 |
Why?
|
| Linear Models | 1 | 2017 | 438 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 2 | 2020 | 725 | 0.120 |
Why?
|
| Pattern Recognition, Automated | 3 | 2009 | 223 | 0.120 |
Why?
|
| DNA, Ribosomal | 1 | 1995 | 55 | 0.120 |
Why?
|
| Middle Aged | 6 | 2021 | 28206 | 0.120 |
Why?
|
| Toxoplasmosis | 1 | 2016 | 70 | 0.120 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 848 | 0.120 |
Why?
|
| Publications | 1 | 2015 | 32 | 0.120 |
Why?
|
| Pedigree | 1 | 2017 | 977 | 0.110 |
Why?
|
| Pharmacogenetics | 1 | 2019 | 456 | 0.110 |
Why?
|
| Bipolar Disorder | 2 | 2008 | 405 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1008 | 0.110 |
Why?
|
| Point Mutation | 1 | 1995 | 247 | 0.110 |
Why?
|
| Genetics, Population | 1 | 2018 | 437 | 0.110 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 1995 | 259 | 0.110 |
Why?
|
| Risk-Taking | 1 | 2015 | 163 | 0.110 |
Why?
|
| Poisson Distribution | 1 | 2014 | 49 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 257 | 0.100 |
Why?
|
| Drosophila melanogaster | 5 | 2009 | 634 | 0.100 |
Why?
|
| Insurance Claim Review | 1 | 2014 | 47 | 0.100 |
Why?
|
| Sequence Analysis, Protein | 2 | 2004 | 28 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2009 | 312 | 0.100 |
Why?
|
| Congenital Abnormalities | 1 | 2014 | 68 | 0.100 |
Why?
|
| Schizophrenia | 2 | 2008 | 532 | 0.100 |
Why?
|
| Qualitative Research | 1 | 2015 | 361 | 0.100 |
Why?
|
| Comorbidity | 4 | 2022 | 1011 | 0.100 |
Why?
|
| Databases as Topic | 3 | 2010 | 96 | 0.100 |
Why?
|
| Species Specificity | 2 | 2018 | 707 | 0.100 |
Why?
|
| Anopheles | 2 | 2003 | 4 | 0.100 |
Why?
|
| Sepsis | 1 | 2017 | 389 | 0.100 |
Why?
|
| Molecular Sequence Data | 10 | 2009 | 3040 | 0.100 |
Why?
|
| Birds | 1 | 1995 | 173 | 0.100 |
Why?
|
| Least-Squares Analysis | 1 | 1992 | 50 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2019 | 1662 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 3 | 2002 | 750 | 0.090 |
Why?
|
| Insect Proteins | 3 | 2002 | 90 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2006 | 2039 | 0.090 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 1192 | 0.090 |
Why?
|
| Inflammation | 1 | 2017 | 1063 | 0.090 |
Why?
|
| Genes, Insect | 3 | 2002 | 184 | 0.090 |
Why?
|
| Philosophy | 1 | 2010 | 9 | 0.080 |
Why?
|
| Concept Formation | 1 | 2010 | 21 | 0.080 |
Why?
|
| Computers | 1 | 2010 | 109 | 0.080 |
Why?
|
| Confidence Intervals | 2 | 2001 | 220 | 0.080 |
Why?
|
| Missouri | 2 | 2020 | 19 | 0.080 |
Why?
|
| Protein Binding | 3 | 2003 | 1560 | 0.080 |
Why?
|
| Receptors, Odorant | 2 | 2001 | 38 | 0.080 |
Why?
|
| Mice | 5 | 2021 | 12537 | 0.080 |
Why?
|
| Amino Acid Sequence | 7 | 2009 | 2090 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2000 | 51 | 0.070 |
Why?
|
| Janus Kinases | 1 | 2009 | 24 | 0.070 |
Why?
|
| Guidelines as Topic | 2 | 2008 | 169 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 3155 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2000 | 157 | 0.070 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2000 | 150 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2014 | 2495 | 0.070 |
Why?
|
| Internet | 2 | 2014 | 340 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 1079 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2022 | 540 | 0.060 |
Why?
|
| HIV Infections | 1 | 2016 | 974 | 0.060 |
Why?
|
| Drosophila Proteins | 4 | 2009 | 523 | 0.060 |
Why?
|
| MEDLINE | 2 | 2002 | 8 | 0.060 |
Why?
|
| Cocaine | 1 | 2006 | 81 | 0.060 |
Why?
|
| Mammals | 2 | 2000 | 261 | 0.060 |
Why?
|
| Probability | 2 | 2008 | 364 | 0.060 |
Why?
|
| Classification | 2 | 2008 | 55 | 0.060 |
Why?
|
| Mathematics | 2 | 1995 | 191 | 0.060 |
Why?
|
| Repressor Proteins | 1 | 2009 | 447 | 0.060 |
Why?
|
| DNA, Mitochondrial | 3 | 1995 | 197 | 0.060 |
Why?
|
| Hominidae | 3 | 1995 | 106 | 0.060 |
Why?
|
| Preventive Medicine | 1 | 2025 | 19 | 0.060 |
Why?
|
| Inappropriate Prescribing | 1 | 2025 | 21 | 0.060 |
Why?
|
| Expert Systems | 1 | 2004 | 18 | 0.060 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2009 | 366 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 750 | 0.050 |
Why?
|
| Treatment Failure | 1 | 2025 | 297 | 0.050 |
Why?
|
| Legionella pneumophila | 1 | 2004 | 66 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 55 | 0.050 |
Why?
|
| Yeasts | 1 | 2004 | 51 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 1878 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 557 | 0.050 |
Why?
|
| Genome, Bacterial | 1 | 2004 | 159 | 0.050 |
Why?
|
| Documentation | 1 | 2004 | 103 | 0.050 |
Why?
|
| Sequence Alignment | 5 | 2003 | 360 | 0.050 |
Why?
|
| Mathematical Computing | 1 | 2002 | 21 | 0.050 |
Why?
|
| Subject Headings | 1 | 2002 | 1 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2003 | 187 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 1046 | 0.050 |
Why?
|
| Clinical Medicine | 1 | 2002 | 34 | 0.050 |
Why?
|
| Alcohol Dehydrogenase | 2 | 2000 | 42 | 0.050 |
Why?
|
| DNA, Bacterial | 2 | 2018 | 253 | 0.050 |
Why?
|
| Biomedical Technology | 1 | 2002 | 26 | 0.050 |
Why?
|
| Japan | 1 | 2022 | 313 | 0.050 |
Why?
|
| Apoptosis | 3 | 2009 | 1756 | 0.050 |
Why?
|
| Mupirocin | 1 | 2021 | 6 | 0.050 |
Why?
|
| Names | 1 | 2002 | 11 | 0.050 |
Why?
|
| Chromosome Deletion | 2 | 2000 | 223 | 0.050 |
Why?
|
| Sphingomyelins | 1 | 2021 | 15 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2021 | 21 | 0.040 |
Why?
|
| Mutation | 4 | 2020 | 4374 | 0.040 |
Why?
|
| Fractals | 1 | 2001 | 42 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 123 | 0.040 |
Why?
|
| Permeability | 1 | 2021 | 144 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2001 | 78 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 1 | 2001 | 44 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2020 | 4664 | 0.040 |
Why?
|
| Software Design | 1 | 2000 | 18 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1998 | 137 | 0.040 |
Why?
|
| Plants | 1 | 2001 | 127 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 1999 | 394 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2021 | 322 | 0.040 |
Why?
|
| Methicillin | 1 | 2019 | 5 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2000 | 52 | 0.040 |
Why?
|
| Cat Diseases | 1 | 2019 | 20 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 528 | 0.040 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2020 | 57 | 0.040 |
Why?
|
| RNA Splicing Factors | 1 | 2000 | 30 | 0.040 |
Why?
|
| Hand Disinfection | 1 | 2019 | 18 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 830 | 0.040 |
Why?
|
| Denmark | 1 | 2019 | 19 | 0.040 |
Why?
|
| Dog Diseases | 1 | 2019 | 37 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 197 | 0.040 |
Why?
|
| Fourier Analysis | 1 | 2000 | 128 | 0.040 |
Why?
|
| Contractile Proteins | 1 | 2000 | 57 | 0.040 |
Why?
|
| Neoplasms | 1 | 2015 | 3242 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2001 | 297 | 0.040 |
Why?
|
| Cats | 1 | 2019 | 305 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 1 | 2000 | 111 | 0.040 |
Why?
|
| Sense Organs | 1 | 1999 | 7 | 0.040 |
Why?
|
| Colon | 1 | 2022 | 542 | 0.040 |
Why?
|
| Policy | 1 | 2019 | 42 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 2019 | 84 | 0.040 |
Why?
|
| Olfactory Receptor Neurons | 1 | 1999 | 17 | 0.040 |
Why?
|
| NIH 3T3 Cells | 1 | 2019 | 112 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 5561 | 0.040 |
Why?
|
| Environmental Pollutants | 1 | 2019 | 56 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2000 | 516 | 0.040 |
Why?
|
| Cloning, Molecular | 4 | 2001 | 648 | 0.040 |
Why?
|
| Environmental Microbiology | 1 | 2018 | 22 | 0.040 |
Why?
|
| Dogs | 1 | 2019 | 718 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2021 | 513 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 7215 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2000 | 446 | 0.040 |
Why?
|
| Cosmids | 1 | 1998 | 22 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2001 | 936 | 0.030 |
Why?
|
| Protein Folding | 1 | 2000 | 295 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1998 | 128 | 0.030 |
Why?
|
| Recurrence | 1 | 2020 | 1211 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2020 | 429 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2019 | 356 | 0.030 |
Why?
|
| Zebrafish | 1 | 2019 | 342 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2016 | 67 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 847 | 0.030 |
Why?
|
| Nematoda | 1 | 1995 | 3 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 160 | 0.030 |
Why?
|
| Eukaryotic Cells | 1 | 1996 | 44 | 0.030 |
Why?
|
| Base Composition | 1 | 1995 | 38 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 859 | 0.030 |
Why?
|
| Decision Trees | 1 | 1995 | 63 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 2777 | 0.030 |
Why?
|
| Arthropods | 1 | 1995 | 33 | 0.030 |
Why?
|
| Computer Systems | 1 | 1994 | 79 | 0.030 |
Why?
|
| Genotype | 1 | 2019 | 1880 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2001 | 1275 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2000 | 1319 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 1995 | 351 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 1995 | 236 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2014 | 70 | 0.030 |
Why?
|
| Health Records, Personal | 1 | 2013 | 11 | 0.030 |
Why?
|
| Biometry | 1 | 1994 | 72 | 0.030 |
Why?
|
| Penetrance | 1 | 2013 | 48 | 0.030 |
Why?
|
| Genetics, Medical | 1 | 2014 | 51 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 301 | 0.030 |
Why?
|
| Bias | 1 | 1994 | 139 | 0.020 |
Why?
|
| Obesity | 1 | 2018 | 1030 | 0.020 |
Why?
|
| Expert Testimony | 1 | 2011 | 34 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 3106 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 2605 | 0.020 |
Why?
|
| Cell Line | 2 | 2009 | 2536 | 0.020 |
Why?
|
| Models, Molecular | 1 | 1995 | 1375 | 0.020 |
Why?
|
| Alternative Splicing | 2 | 2002 | 220 | 0.020 |
Why?
|
| Gene Expression | 1 | 2014 | 1319 | 0.020 |
Why?
|
| Animals, Genetically Modified | 2 | 2001 | 186 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2001 | 422 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2014 | 591 | 0.020 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 2009 | 4 | 0.020 |
Why?
|
| Compound Eye, Arthropod | 1 | 2009 | 7 | 0.020 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2009 | 58 | 0.020 |
Why?
|
| Genome | 2 | 2002 | 407 | 0.020 |
Why?
|
| Nervous System | 1 | 2009 | 92 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2021 | 10273 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 1559 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2009 | 1156 | 0.020 |
Why?
|
| Bacteria | 2 | 2002 | 517 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 563 | 0.010 |
Why?
|
| Gene Transfer, Horizontal | 1 | 2004 | 42 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 1192 | 0.010 |
Why?
|
| Plasmids | 1 | 2004 | 291 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 1135 | 0.010 |
Why?
|
| Sulfolobus solfataricus | 1 | 2002 | 1 | 0.010 |
Why?
|
| Methanobacteriaceae | 1 | 2002 | 2 | 0.010 |
Why?
|
| Catechol Oxidase | 1 | 2002 | 2 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 2003 | 147 | 0.010 |
Why?
|
| Plasmodium | 1 | 2002 | 11 | 0.010 |
Why?
|
| Enzyme Precursors | 1 | 2002 | 20 | 0.010 |
Why?
|
| Serpins | 1 | 2002 | 31 | 0.010 |
Why?
|
| Thermotoga maritima | 1 | 2002 | 16 | 0.010 |
Why?
|
| Parturition | 1 | 2002 | 26 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 435 | 0.010 |
Why?
|
| Bacillus subtilis | 1 | 2002 | 92 | 0.010 |
Why?
|
| Eye Proteins | 1 | 2003 | 130 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2003 | 477 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2002 | 150 | 0.010 |
Why?
|
| Death | 1 | 2002 | 97 | 0.010 |
Why?
|
| Sequence Homology | 1 | 2001 | 28 | 0.010 |
Why?
|
| Animal Structures | 1 | 2001 | 27 | 0.010 |
Why?
|
| Physical Chromosome Mapping | 1 | 2001 | 27 | 0.010 |
Why?
|
| Taste | 1 | 2001 | 29 | 0.010 |
Why?
|
| Chemoreceptor Cells | 1 | 2001 | 65 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2000 | 175 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2001 | 106 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 1167 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2009 | 1730 | 0.010 |
Why?
|
| Transgenes | 1 | 2001 | 186 | 0.010 |
Why?
|
| Larva | 1 | 2001 | 135 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2002 | 246 | 0.010 |
Why?
|
| CD5 Antigens | 1 | 2000 | 13 | 0.010 |
Why?
|
| Smell | 1 | 2001 | 121 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 2000 | 61 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2000 | 156 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 627 | 0.010 |
Why?
|
| Data Collection | 1 | 2001 | 381 | 0.010 |
Why?
|
| Arabidopsis | 1 | 2002 | 331 | 0.010 |
Why?
|
| Peptides | 1 | 2002 | 671 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2002 | 464 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 312 | 0.010 |
Why?
|
| Selection, Genetic | 1 | 2002 | 537 | 0.010 |
Why?
|
| GC Rich Sequence | 1 | 1998 | 9 | 0.010 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1998 | 31 | 0.010 |
Why?
|
| Alu Elements | 1 | 1998 | 16 | 0.010 |
Why?
|
| Eukaryota | 1 | 1998 | 47 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2000 | 357 | 0.010 |
Why?
|
| Fungi | 1 | 1998 | 67 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1998 | 215 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2001 | 829 | 0.010 |
Why?
|
| Lymphoma, B-Cell | 1 | 1998 | 111 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2001 | 677 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2000 | 547 | 0.010 |
Why?
|
| Alleles | 1 | 2000 | 1157 | 0.010 |
Why?
|
| Pongo pygmaeus | 1 | 1995 | 11 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1999 | 593 | 0.010 |
Why?
|
| Gorilla gorilla | 1 | 1995 | 46 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2001 | 2089 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 1998 | 996 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2000 | 1346 | 0.010 |
Why?
|
| Fossils | 1 | 1998 | 388 | 0.010 |
Why?
|
| Pan troglodytes | 1 | 1995 | 205 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1998 | 800 | 0.010 |
Why?
|
| Brain | 1 | 2001 | 2479 | 0.010 |
Why?
|